About Med fusion
Med fusion is a Healthcare company based in Lewisville (United States) founded in 2010, and was acquired by Quest Diagnostics in June 2017. Molecular diagnostics and clinical trials services are provided for oncology. Med fusion has raised $61.25 million across 2 funding rounds from investors including McKesson, Quest Diagnostics and Baylor Scott and White Health. The company has 414 employees. Med fusion offers products and services including Molecular Diagnostics, Clinical Trials Support, and Test Development. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is MED FUSION, LLC. Its competitors include Guardant Health, Natera and Denali Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
With integrated and comprehensive testing services, med fusion offers both disease-specific panels (LUNGSEQ, COLONSEQ, COLONSEQPlus) for prioritizing treatment options within Standard of Care guidelines as well as a hot spot cancer panel (50SEQ) by NGS to support treatment options for rare, refractory, or recurrent disease. The SEQ testing results associate therapy options based upon FDA, NCCN, and ASCO guidelines in a complete and tailored report for the patient and physician. The company projects that by 2016, med fusions solid tumor program will expand to include molecular profiling services for melanoma, glioma, breast, and ovarian cancers. Med Fusion is one of 35 laboratories in the US and three in Texas to be named a Roche Molecular Center of Excellence and also a partner laboratory for the US Oncology Network and Texas Oncology.
- Headquarters Lewisville, United States
- Employees 414
- Stage Acquired
- SectorsHealthcare
- Website medfusionservices.com
- Social LinkedIn
- Acquired by Quest Diagnostics (Jun 2017)
- Legal Name Med Fusion, Llc
- Total Equity Funding$61.25M (USD)
in 2 rounds
- Latest Funding Round$61.25M (USD), Series B
Jan 2014
- InvestorsMcKesson
& 4 more
- Employee Count414
- Acquired byQuest Diagnostics
(Jun 2017)
Products & Services of Med fusion
Med fusion offers a comprehensive portfolio of products and services, including Molecular Diagnostics, Clinical Trials Support, and Test Development.
Provides testing for molecular analysis in healthcare settings.
Assists with trial management for biotech and pharmaceutical firms.
Develops and validates diagnostic tests for medical applications.
Funding Insights of Med fusion
Med fusion has successfully raised a total of $61.25M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $61.25 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.25M
- Total Rounds 2
- Last Round Series B — $61.25M
- Investors Count 4
All 2 funding rounds of Med fusion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | $61.25M | Series B | – | Pathologist, Texas Oncology | – |
| Mar 2012 | Debt – Conventional | – | – | – |
5 investors in total: 5 institutional.
Investors in Med fusion
Med fusion has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include McKesson, Quest Diagnostics and Baylor Scott and White Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pathology laboratory services are provided via a chain of facilities. | 1997 | pbmlabs.com | Dallas, United States | |
Texas Oncology is recognized for providing comprehensive cancer care services. | texasoncology.com | United States | ||
Products and services are provided in the healthcare industry. | 1833 | mckesson.com | Irving, United States | |
Provider of healthcare through urgent care, online platforms, and specialized programs | 1903 | bswhealth.com | United States | |
Integrated diagnostic and IT services are provided to healthcare organizations. | 1967 | questdiagnostics.com | Madison, United States |
Investor details for Med fusion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Med fusion
2 people are tracked at Med fusion (2 in leadership); the tracked headcount is 414.
| Name | Role | Group |
|---|---|---|
Benton Middleman | Medical Director | Leadership |
Jon Hart | Chief Executive Officer | Leadership |
Complete people profiles for Med fusion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Med fusion
4 dated milestones of Med fusion across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Med fusion is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $61.2M.
- Exit Acquired by Quest Diagnostics.
Competitors of Med fusion
Med fusion has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Natera and Denali Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. |
Detailed competitors of Med fusion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Med fusion
The website of Med fusion (medfusionservices.com) receives about 8K visits a month.
- Monthly visits8K
▲ 34.9% vs previous month
Websites whose visitors overlap most with Med fusion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medfusion.com | 100% | 1.2K | #14,387,338 | View details | |
healthcareitnews.com | healthcareitnews.com | 85% | #409,888 | – | |
| nextgen.com | 84% | 3.1M | #17,633 | View details | |
| greatcircle.org | 62% | View details | |||
discoverylifesciences.com | discoverylifesciences.com | 55% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Med fusion
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Med fusion (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Med fusion
Med fusion was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Med fusion is headquartered in Lewisville, United States. It is registered at Lewisville, Texas, United States.
Med fusion is a funded company, having raised a total of $61.25M across 2 funding rounds to date.
Med fusion has 414 employees.
With integrated and comprehensive testing services, med fusion offers both disease-specific panels (LUNGSEQ, COLONSEQ, COLONSEQPlus) for prioritizing treatment options within Standard of Care guidelines as well as a hot spot cancer panel (50SEQ) by NGS to support treatment options for rare, refractory, or recurrent disease. The SEQ testing results associate therapy options based upon FDA, NCCN, and ASCO guidelines in a complete and tailored report for the patient and physician. The company projects that by 2016, med fusions solid tumor program will expand to include molecular profiling services for melanoma, glioma, breast, and ovarian cancers. Med Fusion is one of 35 laboratories in the US and three in Texas to be named a Roche Molecular Center of Excellence and also a partner laboratory for the US Oncology Network and Texas Oncology.
Med fusion's top competitors include Guardant Health, Natera and Denali Therapeutics.
Med fusion offers Molecular Diagnostics, Clinical Trials Support, and Test Development.
Med fusion has 5 investors. Key investors include McKesson, Quest Diagnostics, Baylor Scott and White Health, Pathologist, and Texas Oncology.
Med fusion operates through Med Fusion, Llc.
Yes. Med fusion was acquired by Quest Diagnostics in June 2017.